Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lymphoma Clinical Trials in Seattle | 516 Studies

Clinical Trials LymphomaSeattle

Lymphoma Clinical Trials in Seattle

Find 516 clinical trials for lymphoma near Seattle, Washington. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Seattle

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 381-400 of 516 trials

CompletedCrizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell LymphomaThis phase 1/2 trial the studies side effects and best dose of crizotinib and to see how well it works in treating young patients with solid tumors or anaplastic large cell…NCT00939770·Birmingham, Alabama and 27 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedBortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin LymphomaRATIONALE: Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the cancer.NCT00598169·La Jolla, California and 16 others

RecruitingTesting the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaThis phase II trial tests the addition of venetoclax and/or blinatumomab to usual chemotherapy for treating infants with newly diagnosed acute lymphoblastic leukemia (ALL) with a…NCT06317662·Birmingham, Alabama and 116 others

TerminatedDecision Making Tool for Firearm StorageThis is a one-arm pilot study testing the feasibility and acceptability of a decision aid about safe firearm storage.NCT06382194·Seattle, Washington

TerminatedPembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell LymphomaThis phase II trial studies how well pembrolizumab with rituximab or obinutuzumab work in treating patients with follicular lymphoma or diffuse large B cell lymphoma that has come…NCT03401853·Seattle, Washington

CompletedSirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationRATIONALE: Sirolimus, tacrolimus, and methotrexate may be effective in preventing acute graft-versus-host disease in patients who are undergoing donor stem cell transplantation.NCT00089037·Seattle, Washington

Active not recruitingA Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular LymphomaThis study will evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of mosunetuzumab (Mosun) + lenalidomide (Len) (Mosun + Len) in participants with follicular…NCT04246086·Duarte, California and 25 others

CompletedThe "Let's Talk Tech" Tool to Support Decision Making About Technology UseThe goal of this research is to educate people about different technologies to support care at home when someone is experiencing memory difficulties.NCT06817122·Seattle, Washington

CompletedEfficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin LymphomasThe primary objective will be to assess the overall response rate and to evaluate the efficacy and safety of idelalisib (IDELA; GS-1101) in participants with previously treated…NCT01282424·Fullerton, California and 40 others

TerminatedhuJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaThis phase I trial studies the side effects of huJCAR014 in treating patients with relapsed or refractory B-cell non-Hodgkin lymphoma or acute lymphoblastic leukemia. huJCAR014…NCT03103971·Seattle, Washington

CompletedSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyThis phase I trial studies the side effects and the best dose of sunitinib malate in treating human immunodeficiency virus (HIV)-positive patients with cancer receiving…NCT00890747·Los Angeles, California and 10 others

CompletedA Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin LymphomaThis is an open-label, multicenter, phase 2 clinical trial to evaluate the efficacy and safety of brentuximab vedotin as a single agent in patients with CD30-positive non-Hodgkin…NCT01421667·Birmingham, Alabama and 33 others

TerminatedA Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid TumorsMulticenter, open-label, phase 1a/1b trial of PF-07901800 (TTI-621) in subjects with relapsed or refractory hematologic malignancies and selected solid tumors.NCT02663518·Duarte, California and 50 others

Active not recruitingStudy of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in WaldenstromPart A of this study evaluates iopofosine I 131 (CLR 131) in patients with select B-cell malignancies (multiple myeloma( MM), indolent chronic lymphocytic leukemia (CLL)/small…NCT02952508·Los Angeles, California and 51 others

CompletedForodesine in the Treatment of Cutaneous T-Cell LymphomaThis is a Phase II, non-randomized, open-label, single-arm trial that will be conducted at up to 50 sites in North America, Europe and Australia.NCT00501735·Birmingham, Alabama and 40 others

CompletedCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00003150·Mobile, Alabama and 90 others

CompletedClinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaThe purpose of this study is to determine the dose of the bispecific T cell engager blinatumomab (MT103) in pediatric and adolescent patients with relapsed/refractory acute…NCT01471782·Aurora, Colorado and 29 others

CompletedPembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary SyndromeThis phase II trial studies how well pembrolizumab works in treating patients with stage IB-IVB mycosis fungoides or Sezary syndrome that has returned after a period of…NCT02243579·Palo Alto, California and 7 others

TerminatedStudy to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins LymphomaUnity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in…NCT02793583·Birmingham, Alabama and 167 others

CompletedSafety and Efficacy Study of a BTK Inhibitor in Subjects With Relapsed or Refractory Diffuse Large B-cell LymphomaThe purpose of this study is to evaluate the efficacy of ibrutinib (PCI-32765) in relapsed/refractory de novo activated B-cell (ABC) and germinal-cell B-Cell (GCB) Diffuse Large…NCT01325701·Los Angeles, California and 14 others

PreviousPage 20 of 26Next

Other Conditions in Seattle

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia